Literature DB >> 18240950

Adoptive CD8 T cell control of pathogens cannot be improved by combining protective epitope specificities.

Rafaela Holtappels1, Jozef Janda, Doris Thomas, Simone Schenk, Matthias J Reddehase, Gernot Geginat.   

Abstract

Adoptive transfer of CD8 T cells has the potential to cure infectious or malignant diseases that are refractory to conventional chemotherapy. A practically important but still unanswered question is whether mixtures of protective CD8 T cells with different epitope specificities mediate more efficient effector cell functions than do the monospecific individual CD8 T cell populations. In this study, we have addressed this issue for models of viral and bacterial infection. CD8 T cell-mediated cytotoxicity in vitro and protection in vivo were assessed to test whether CD8 T cell lines cooperate in target cell lysis and control of infection, respectively. Our data clearly show that mixtures of cytolytic T cell lines specific for different epitopes of either murine cytomegalovirus or Listeria monocytogenes do not act synergistically. An efficient anti-infectious protection thus proved to be dependent primarily on the number of transferred protective CD8 T cells rather than on the cooperative effects of multiple specificities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240950     DOI: 10.1086/526791

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 2.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

Review 3.  Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.

Authors:  Stefan Ebert; Jürgen Podlech; Dorothea Gillert-Marien; Kerstin M Gergely; Julia K Büttner; Annette Fink; Kirsten Freitag; Doris Thomas; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 3.402

4.  Spatial distribution and structural arrangement of a murine cytomegalovirus glycoprotein detected by SPDM localization microscopy.

Authors:  Patrick Müller; Niels A Lemmermann; Rainer Kaufmann; Manuel Gunkel; Daniel Paech; Georg Hildenbrand; Rafaela Holtappels; Christoph Cremer; Michael Hausmann
Journal:  Histochem Cell Biol       Date:  2014-02-07       Impact factor: 4.304

Review 5.  Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.

Authors:  Niels A W Lemmermann; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

6.  Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.

Authors:  Kerstin M Gergely; Jürgen Podlech; Sara Becker; Kirsten Freitag; Steffi Krauter; Nicole Büscher; Rafaela Holtappels; Bodo Plachter; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

7.  Acute neonatal infections 'lock-in' a suboptimal CD8+ T cell repertoire with impaired recall responses.

Authors:  Brian D Rudd; Vanessa Venturi; Norah L Smith; Kito Nzingha; Emily L Goldberg; Gang Li; Janko Nikolich-Zugich; Miles P Davenport
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.